In persons with CIDP, auto-HSCT can be conducted fully on an outpatient basis and induces significant clinical responses: A prospective study in a single center

Chronic inflammatory demyelinating polyneuropathy (CIDP) is one of the world's most common treatable neuropathy which usually responds to immunosuppressive treatment. Autologous hematopoietic stem cell transplantation (aHSCT) is an intense way of inducing immunosuppression. We analyze the evolu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplant immunology 2023-12, Vol.81, p.101944-101944, Article 101944
Hauptverfasser:	Montes-Robles, Merittzel Abigail, Gallardo-Pérez, Moisés Manuel, Hernández-Flores, Edgar J., Pastelín-Martínez, María de Lourdes, Sánchez-Bonilla, Daniela, Robles-Nasta, Max, Ocaña-Ramm, Guillermo, Olivares-Gazca, Juan Carlos, Ruiz-Delgado, Guillermo J., Ruiz-Argüelles, Guillermo J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoimmune disorders CIDP Hematopoietic Stem Cell Transplantation - methods HSCT Humans I-RODS Immunosuppressive Agents - therapeutic use INCAT Outpatients Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!